The global ambulatory blood pressure monitoring devices market was valued at $160.8 million in 2021, and is projected to reach $309.3 million by 2031, registering a CAGR of 6.7% from 2022 to 2031.
Ambulatory blood pressure monitoring (ABPM) devices are portable blood pressure recording devices used to record blood pressure readings during 24-hour period. These non-invasive instruments can be continuously carried by a patient in their own environment. The patient is connected to the ABPM device by a belt around his or her body and a cuff is placed around the upper arm. Patients can perform their daily task by wearing these monitoring devices as these devices are small and compatible in size. Blood pressure is one of the main risk factors for chronic heart disease and strokes, which are the leading cause of death around the world. This results in increase in importance of blood pressure monitoring devices in home care settings.
The major driver of the ABPM market includes rise in high demand for non-invasive method of measuring blood pressure, and initiatives taken by government such as launching various blood pressure monitoring programs for creating awareness among people to maintain their health. In addition, prominent players have adopted product development including product launches and approvals, as their key developmental strategies to expand their product portfolio. Moreover, reimbursement policies for blood pressure monitoring devices have fueled the demand for these products. For instance, Medicare offers reimbursement for ambulatory blood pressure monitoring (ABPM) devices used for a patient receiving blood dialysis at home or suffering from white coat hypertension. Moreover, high blood pressure is one of the most important risk factor for cardiovascular disease. High blood pressure can damage arteries which can decrease the flow of blood and oxygen to heart and cause heart disease. Approximately 54% of stroke and 47% of coronary heart diseases are attributable to high blood pressure. Thus, rise in number of cases of high blood pressure leads to increase in the demand for ambulatory blood pressure monitoring devices driving the growth of the market. Moreover, cardiovascular diseases (CVDs) are the leading causes of death globally, and it takes an estimated 17.9 million lives each year. According to the report by the British Heart Foundation, in 2021, a total of 7.6 million people live with heart & circulatory diseases and it causes about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart & blood vessels and include, coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Thus, rise in demand to measure the blood pressure continuously among patients with severe hypertension is expected to contribute toward the growth of the ambulatory blood pressure monitoring devices market.
Furthermore, rise in demand for remote patient monitoring is to fill the gaps in existing heart failure problems and increase in advancement in technologies such as mobile-based blood pressure monitoring systems are anticipated to drive the growth of the market. For instance, in June 2021, Biobeat has launched new cuffless ambulatory blood pressure monitoring device. This novel ABPM device also measures cardiac output, stoke volume, systemic vascular resistance, and heart rate of an individual’s health. In addition, in November 2021, Baxter International Inc., acquired Cheetah Medical, which is leading provider of non-invasive hemodynamic monitoring devices. This acquisition helped Baxter to expand its business in the specialized patient monitoring space. Thus, increase in number of product launches and acquisitions among key players propels the growth of the market.
According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes. The total number of people living with diabetes is projected to increase to 643 million by 2045. Thus, shift of people toward sedentary lifestyle is increasing the incidence of diabetes and hypertension. This further propels the demand for portable monitoring devices, which is anticipated to foster the growth of the ambulatory blood patient monitoring devices market. In addition, there has been a continuous increase in the prevalence of cardiovascular diseases in China. As per the report published in the Journal of Geriatric Cardiology by Li-Yuan Ma, in China, in 2020, over 290 million individuals suffered from cardiovascular diseases and nearly 2 out of every 5 fatalities occurred due to cardiovascular disease. Therefore, rise in number of cardiovascular diseases results in increase in number of surgeries. This leads to increase in usage of ambulatory blood pressure monitoring devices for diagnosis that further boosts the growth of the market. In addition, according to World Health Organization, in 2019, approximately 1.28 billion people suffered from hypertension, which is the main cause of death. Thus, rise in number of cases of people suffering from hypertension leads to increase in the usage of ambulatory blood pressure monitoring devices. This, in turn, drives the growth of the market.
The demand for ambulatory blood pressure monitoring devices is expected to increase globally during market analysis, owing to rise in incidence of chronic diseases and rapid increase in geriatric population. Moreover, increase in healthcare expenditure in emerging economies and high demand for proactive monitoring are expected to provide new opportunities for market players. However, lack of awareness in developing regions is anticipated to hamper the market growth. In addition, Oscar 2 ambulatory blood pressure monitoring which is provide by SunTech Medical is used to measure accurate blood pressure in patients and is gaining immense popularity in the market. Thus, presence of innovative ambulatory blood pressure monitoring devices drives the growth of the market. The ambulatory blood pressure monitoring devices market is segmented into product, end user, and region. By product, it is bifurcated into arm and wrist ABPM devices. By end user, it is divided into hospitals, ambulatory surgical centers (ASCs), and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Baxter International Inc., Bosch+Sohn GmbH Co KG, BPL Ltd, Contec Medical Systems Co., Ltd, GE Healthcare, Halma Plc, Omron Corporation, OSI Systems Inc. (Spacelabs Healthcare Inc.), Schiller AG, and Vaso Corporation.
Ambulatory blood pressure monitoring (ABPM) devices are portable blood pressure recording devices used to record blood pressure readings during 24-hour period. These non-invasive instruments can be continuously carried by a patient in their own environment. The patient is connected to the ABPM device by a belt around his or her body and a cuff is placed around the upper arm. Patients can perform their daily task by wearing these monitoring devices as these devices are small and compatible in size. Blood pressure is one of the main risk factors for chronic heart disease and strokes, which are the leading cause of death around the world. This results in increase in importance of blood pressure monitoring devices in home care settings.
The major driver of the ABPM market includes rise in high demand for non-invasive method of measuring blood pressure, and initiatives taken by government such as launching various blood pressure monitoring programs for creating awareness among people to maintain their health. In addition, prominent players have adopted product development including product launches and approvals, as their key developmental strategies to expand their product portfolio. Moreover, reimbursement policies for blood pressure monitoring devices have fueled the demand for these products. For instance, Medicare offers reimbursement for ambulatory blood pressure monitoring (ABPM) devices used for a patient receiving blood dialysis at home or suffering from white coat hypertension. Moreover, high blood pressure is one of the most important risk factor for cardiovascular disease. High blood pressure can damage arteries which can decrease the flow of blood and oxygen to heart and cause heart disease. Approximately 54% of stroke and 47% of coronary heart diseases are attributable to high blood pressure. Thus, rise in number of cases of high blood pressure leads to increase in the demand for ambulatory blood pressure monitoring devices driving the growth of the market. Moreover, cardiovascular diseases (CVDs) are the leading causes of death globally, and it takes an estimated 17.9 million lives each year. According to the report by the British Heart Foundation, in 2021, a total of 7.6 million people live with heart & circulatory diseases and it causes about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart & blood vessels and include, coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Thus, rise in demand to measure the blood pressure continuously among patients with severe hypertension is expected to contribute toward the growth of the ambulatory blood pressure monitoring devices market.
Furthermore, rise in demand for remote patient monitoring is to fill the gaps in existing heart failure problems and increase in advancement in technologies such as mobile-based blood pressure monitoring systems are anticipated to drive the growth of the market. For instance, in June 2021, Biobeat has launched new cuffless ambulatory blood pressure monitoring device. This novel ABPM device also measures cardiac output, stoke volume, systemic vascular resistance, and heart rate of an individual’s health. In addition, in November 2021, Baxter International Inc., acquired Cheetah Medical, which is leading provider of non-invasive hemodynamic monitoring devices. This acquisition helped Baxter to expand its business in the specialized patient monitoring space. Thus, increase in number of product launches and acquisitions among key players propels the growth of the market.
According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes. The total number of people living with diabetes is projected to increase to 643 million by 2045. Thus, shift of people toward sedentary lifestyle is increasing the incidence of diabetes and hypertension. This further propels the demand for portable monitoring devices, which is anticipated to foster the growth of the ambulatory blood patient monitoring devices market. In addition, there has been a continuous increase in the prevalence of cardiovascular diseases in China. As per the report published in the Journal of Geriatric Cardiology by Li-Yuan Ma, in China, in 2020, over 290 million individuals suffered from cardiovascular diseases and nearly 2 out of every 5 fatalities occurred due to cardiovascular disease. Therefore, rise in number of cardiovascular diseases results in increase in number of surgeries. This leads to increase in usage of ambulatory blood pressure monitoring devices for diagnosis that further boosts the growth of the market. In addition, according to World Health Organization, in 2019, approximately 1.28 billion people suffered from hypertension, which is the main cause of death. Thus, rise in number of cases of people suffering from hypertension leads to increase in the usage of ambulatory blood pressure monitoring devices. This, in turn, drives the growth of the market.
The demand for ambulatory blood pressure monitoring devices is expected to increase globally during market analysis, owing to rise in incidence of chronic diseases and rapid increase in geriatric population. Moreover, increase in healthcare expenditure in emerging economies and high demand for proactive monitoring are expected to provide new opportunities for market players. However, lack of awareness in developing regions is anticipated to hamper the market growth. In addition, Oscar 2 ambulatory blood pressure monitoring which is provide by SunTech Medical is used to measure accurate blood pressure in patients and is gaining immense popularity in the market. Thus, presence of innovative ambulatory blood pressure monitoring devices drives the growth of the market. The ambulatory blood pressure monitoring devices market is segmented into product, end user, and region. By product, it is bifurcated into arm and wrist ABPM devices. By end user, it is divided into hospitals, ambulatory surgical centers (ASCs), and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Baxter International Inc., Bosch+Sohn GmbH Co KG, BPL Ltd, Contec Medical Systems Co., Ltd, GE Healthcare, Halma Plc, Omron Corporation, OSI Systems Inc. (Spacelabs Healthcare Inc.), Schiller AG, and Vaso Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ambulatory blood pressure monitoring (abpm) devices market analysis from 2021 to 2031 to identify the prevailing ambulatory blood pressure monitoring (abpm) devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ambulatory blood pressure monitoring (abpm) devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global ambulatory blood pressure monitoring (abpm) devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Arm ABPM Devices
- Wrist ABPM Devices
By End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- BOSCH & SOHN GmbH & CO. KG
- BPL LTD.
- CONTEC MEDICAL SYSTEMS CO. LTD.
- GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
- HALMA PLC.
- BAXTER (HILL ROM HOLDINGS, INC.)
- Omron Corporation
- OSI Systems, Inc. (Spacelabs Healthcare, Inc.)
- SCHILLER AG
- VASO CORPORATION
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: AMBULATORY BLOOD PRESSURE MONITORING (ABPM) DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Arm ABPM Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Wrist ABPM Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: AMBULATORY BLOOD PRESSURE MONITORING (ABPM) DEVICES MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Ambulatory Surgical Centers (ASCs)
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: AMBULATORY BLOOD PRESSURE MONITORING (ABPM) DEVICES MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Product
6.2.4.1.2 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Product
6.2.4.2.2 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Product
6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Product
6.3.4.1.2 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Product
6.3.4.2.2 Market size and forecast, by End User
6.3.4.3 UK
6.3.4.3.1 Market size and forecast, by Product
6.3.4.3.2 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Product
6.3.4.4.2 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Product
6.3.4.5.2 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Product
6.3.4.6.2 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Product
6.4.4.1.2 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Product
6.4.4.2.2 Market size and forecast, by End User
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Product
6.4.4.3.2 Market size and forecast, by End User
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Product
6.4.4.4.2 Market size and forecast, by End User
6.4.4.5 South Korea
6.4.4.5.1 Market size and forecast, by Product
6.4.4.5.2 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Product
6.4.4.6.2 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Product
6.5.4.1.2 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Product
6.5.4.2.2 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Product
6.5.4.3.2 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Product
6.5.4.4.2 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 BOSCH & SOHN GmbH & CO. KG
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 BPL LTD.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 CONTEC MEDICAL SYSTEMS CO. LTD.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 HALMA PLC.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 BAXTER (HILL ROM HOLDINGS, INC.)
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Omron Corporation
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 OSI Systems, Inc. (Spacelabs Healthcare, Inc.)
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 SCHILLER AG
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 VASO CORPORATION
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 2. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market Size, for Arm Abpm Devices, by Region, 2021-2031 ($Million)
Table 3. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market for Arm Abpm Devices, by Country, 2021-2031 ($Million)
Table 4. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market Size, for Wrist Abpm Devices, by Region, 2021-2031 ($Million)
Table 5. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market for Wrist Abpm Devices, by Country, 2021-2031 ($Million)
Table 6. Global Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 7. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market Size, for Hospitals, by Region, 2021-2031 ($Million)
Table 8. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market for Hospitals, by Country, 2021-2031 ($Million)
Table 9. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market Size, for Ambulatory Surgical Centers (Ascs), by Region, 2021-2031 ($Million)
Table 10. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market for Ambulatory Surgical Centers (Ascs), by Country, 2021-2031 ($Million)
Table 11. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market Size, for Others, by Region, 2021-2031 ($Million)
Table 12. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market for Others, by Country, 2021-2031 ($Million)
Table 13. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Region, 2021-2031 ($Million)
Table 14. North America Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 15. North America Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 16. North America Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Country, 2021-2031 ($Million)
Table 17. U.S. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 18. U.S. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 19. Canada Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 20. Canada Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 21. Mexico Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 22. Mexico Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 23. Europe Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 24. Europe Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 25. Europe Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Country, 2021-2031 ($Million)
Table 26. Germany Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 27. Germany Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 28. France Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 29. France Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 30. UK Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 31. UK Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 32. Italy Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 33. Italy Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 34. Spain Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 35. Spain Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 36. Rest of Europe Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 37. Rest of Europe Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 38. Asia-Pacific Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 39. Asia-Pacific Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 40. Asia-Pacific Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Country, 2021-2031 ($Million)
Table 41. Japan Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 42. Japan Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 43. China Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 44. China Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 45. Australia Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 46. Australia Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 47. India Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 48. India Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 49. South Korea Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 50. South Korea Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 51. Rest of Asia-Pacific Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 52. Rest of Asia-Pacific Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 53. LAMEA Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 54. LAMEA Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 55. LAMEA Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Country, 2021-2031 ($Million)
Table 56. Brazil Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 57. Brazil Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 58. Saudi Arabia Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 59. Saudi Arabia Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 60. South Africa Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 61. South Africa Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 62. Rest of LAMEA Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by Product, 2021-2031 ($Million)
Table 63. Rest of LAMEA Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, by End-user, 2021-2031 ($Million)
Table 64. Bosch & Sohn GmbH & Co. KG: Company Snapshot
Table 65. Bosch & Sohn GmbH & Co. KG: Operating Segments
Table 66. Bosch & Sohn GmbH & Co. KG: Product Portfolio
Table 67. Bosch & Sohn GmbH & Co. KG: Net Sales
Table 68. Bosch & Sohn GmbH & Co. KG: Key Strategies
Table 69. Bpl Ltd.: Company Snapshot
Table 70. Bpl Ltd.: Operating Segments
Table 71. Bpl Ltd.: Product Portfolio
Table 72. Bpl Ltd.: Net Sales
Table 73. Bpl Ltd.: Key Strategies
Table 74. Contec Medical Systems Co. Ltd.: Company Snapshot
Table 75. Contec Medical Systems Co. Ltd.: Operating Segments
Table 76. Contec Medical Systems Co. Ltd.: Product Portfolio
Table 77. Contec Medical Systems Co. Ltd.: Net Sales
Table 78. Contec Medical Systems Co. Ltd.: Key Strategies
Table 79. GE Healthcare (A Healthcare Division of GE Company): Company Snapshot
Table 80. GE Healthcare (A Healthcare Division of GE Company): Operating Segments
Table 81. GE Healthcare (A Healthcare Division of GE Company): Product Portfolio
Table 82. GE Healthcare (A Healthcare Division of GE Company): Net Sales
Table 83. GE Healthcare (A Healthcare Division of GE Company): Key Strategies
Table 84. Halma PLC.: Company Snapshot
Table 85. Halma PLC.: Operating Segments
Table 86. Halma PLC.: Product Portfolio
Table 87. Halma PLC.: Net Sales
Table 88. Halma PLC.: Key Strategies
Table 89. Baxter (Hill Rom Holdings, Inc.): Company Snapshot
Table 90. Baxter (Hill Rom Holdings, Inc.): Operating Segments
Table 91. Baxter (Hill Rom Holdings, Inc.): Product Portfolio
Table 92. Baxter (Hill Rom Holdings, Inc.): Net Sales
Table 93. Baxter (Hill Rom Holdings, Inc.): Key Strategies
Table 94. Omron Corporation: Company Snapshot
Table 95. Omron Corporation: Operating Segments
Table 96. Omron Corporation: Product Portfolio
Table 97. Omron Corporation: Net Sales
Table 98. Omron Corporation: Key Strategies
Table 99. Osi Systems, Inc. (Spacelabs Healthcare, Inc.): Company Snapshot
Table 100. Osi Systems, Inc. (Spacelabs Healthcare, Inc.): Operating Segments
Table 101. Osi Systems, Inc. (Spacelabs Healthcare, Inc.): Product Portfolio
Table 102. Osi Systems, Inc. (Spacelabs Healthcare, Inc.): Net Sales
Table 103. Osi Systems, Inc. (Spacelabs Healthcare, Inc.): Key Strategies
Table 104. Schiller AG: Company Snapshot
Table 105. Schiller AG: Operating Segments
Table 106. Schiller AG: Product Portfolio
Table 107. Schiller AG: Net Sales
Table 108. Schiller AG: Key Strategies
Table 109. Vaso Corporation: Company Snapshot
Table 110. Vaso Corporation: Operating Segments
Table 111. Vaso Corporation: Product Portfolio
Table 112. Vaso Corporation: Net Sales
Table 113. Vaso Corporation: Key Strategies
List of Figures
Figure 1. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market Segmentation
Figure 2. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031
Figure 3. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Ambulatory Blood Pressure Monitoring (Abpm) Devices Mark.:Drivers, Restraints and Opportunities
Figure 12. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, By Product, 2021(%)
Figure 13. Comparative Share Analysis of Arm Abpm Devices Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Wrist Abpm Devices Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031(%)
Figure 15. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, By End-user, 2021(%)
Figure 16. Comparative Share Analysis of Hospitals Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031(%)
Figure 17. Comparative Share Analysis of Ambulatory Surgical Centers (Ascs) Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Others Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031(%)
Figure 19. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market by Region, 2021
Figure 20. U.S. Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 21. Canada Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 22. Mexico Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 23. Germany Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 24. France Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 25. Uk Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 26. Italy Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 27. Spain Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 28. Rest of Europe Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 29. Japan Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 30. China Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 31. Australia Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 32. India Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 33. South Korea Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 34. Rest of Asia-Pacific Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 35. Brazil Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 36. Saudi Arabia Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 37. South Africa Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 38. Rest of LAMEA Ambulatory Blood Pressure Monitoring (Abpm) Devices Market, 2021-2031($Million)
Figure 39. Top Winning Strategies, by Year
Figure 40. Top Winning Strategies, by Development
Figure 41. Top Winning Strategies, by Company
Figure 42. Product Mapping of Top 10 Players
Figure 43. Competitive Dashboard
Figure 44. Competitive Heatmap of Top 10 Key Players
Figure 45. Bosch & Sohn GmbH & Co. K.: Net Sales, ($Million)
Figure 46. Bpl Ltd.: Net Sales, ($Million)
Figure 47. Contec Medical Systems Co. Ltd.: Net Sales, ($Million)
Figure 48. Ge Healthcare (A Healthcare Division of GE Company.: Net Sales, ($Million)
Figure 49. Halma plc.: Net Sales, ($Million)
Figure 50. Baxter (Hill Rom Holdings, Inc..: Net Sales, ($Million)
Figure 51. Omron Corporatio.: Net Sales, ($Million)
Figure 52. Osi Systems, Inc. (Spacelabs Healthcare, Inc..: Net Sales, ($Million)
Figure 53. Schiller A.: Net Sales, ($Million)
Figure 54. Vaso Corporatio.: Net Sales, ($Million)
Executive Summary
According to the report, “Ambulatory Blood Pressure Monitoring (ABPM) Devices Market," the ambulatory blood pressure monitoring devices Market size was valued at $160.80 million in 2021, and is estimated to reach $309.3 million by 2031, growing at a CAGR of 6.7% from 2022 to 2031.ABPM devices measure ambulatory blood pressure and are designed to avoid the effects of white coat hypertension, while providing accurate sleep blood pressure readings. Ambulatory blood pressure monitoring is a diagnostic test which is used to determine the presence of hypertension by measuring blood pressure during daily activities for 24 hours. This device is a portable blood pressure machine worn as a belt, in which cuff is attached around the upper arm of the body. It can be used to confirm a detection of high blood pressure, which is called as white-coat hypertension.
The global ABPM devices market size is driven by rise in number of hypertension cases due to obesity, cardiovascular diseases, and diabetes. Moreover, growth in geriatric population, high demand for non-invasive devices for measuring blood pressure, and transformation from physician-centered to the patient-centered model fuel the growth of the market. For instance, in August 2022, CariAI Inc. introduced new 24-hour ambulatory blood pressure monitoring system namely BPAro. It is a compact portable blood pressure monitoring device which automatically records patient blood pressure. In addition, in January 2021, Aktila SA launched a 24/7 automated blood pressure monitoring system in the U.S. Moreover, in June 2019, A&D Medical, which is a global leader in blood pressure monitoring solutions, launched new line of professional blood pressure monitors which helps clinicians to diagnose hypertension and manage blood pressure level. This new line of products includes ambulatory blood pressure monitors and professional office blood pressure monitors. This next generation ambulatory blood pressure is used in diagnosis and assessment of hypertension. Both of these models, namely TM-2440 and TM-2441 are lightweight and help improve patient compliance. The TM-2441 model has high tech sensor which records environmental parameters along with blood pressure measurements for 24 hours. Thus, increase in in number of product launches by key players drives the ambulatory blood pressure monitoring devices market growth.
Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive use of ambulatory blood pressure monitoring devices post-surgery to detect blood pressure level propel the growth of the market. Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the ambulatory blood pressure monitoring devices market.
For instance, in January 2020, Omron Corporation launched HeartGuide device. This device is a wearable product that monitors blood pressure. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the ambulatory blood pressure monitoring (ABPM) devices market.
However, expensive ABPM monitors and lack of awareness in emerging regions are expected to restrain the market growth. Conversely, huge market potential in the emerging markets, such as China and India, and increase in healthcare expenditure in developing countries are expected to provide lucrative opportunities to the market players.
The ABPM devices market is segmented into product, end user and region. By product, it is bifurcated into arm blood pressure monitoring devices and wrist blood pressure monitoring devices. The arm ABPM device segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period attributed to the surge in usage of ambulatory blood pressure monitors.
By end user, it is divided into hospitals, ambulatory surgical centers (ASCs), and others. The hospitals segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period attributed to increase in number of hospital admissions.
By region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest ambulatory blood pressure monitoring devices market share in 2021, and is expected to remain dominant throughout the forecast period, owing to increase in large number of key players in the region which provide wide range of ambulatory blood pressure monitoring devices.
The key players that operate in the ABPM devices industry include Baxter International Inc., Bosch+Sohn GmbH Co KG, BPL Ltd, Contec Medical Systems Co., Ltd, GE Healthcare, Halma Plc, Omron Corporation, OSI Systems Inc. (Spacelabs Healthcare Inc.), Schiller AG, and Vaso Corporation.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market size, and the current ambulatory blood pressure monitoring devices market trends & future estimations to elucidate imminent investment pockets.It presents a quantitative analysis of the market from 2021 to 2031 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Companies Mentioned
- BOSCH & SOHN GmbH & CO. KG
- BPL LTD.
- CONTEC MEDICAL SYSTEMS CO. LTD.
- GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
- HALMA PLC.
- BAXTER (HILL ROM HOLDINGS, INC.)
- Omron Corporation
- OSI Systems, Inc. (Spacelabs Healthcare, Inc.)
- SCHILLER AG
- VASO CORPORATION
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | September 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 160.8 million |
| Forecasted Market Value ( USD | $ 309.3 million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
